EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Analysis of Adverse Drug Reactions to Common Drugs Administered to COVID-19 Patients: The Role of Pharmacovigilance System in Public Medical Centers

Hyesu Jeong, Gunn Hee Kim, Sung-chul Ko, Ji Eun Kang

Journal of Pharmacoepidemiology and Risk Management · 2021

DOI: 10.56142/2022.13.1.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, 2021. Verfasst von Hyesu Jeong und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The world is experiencing the coronavirus disease (COVID-19) pandemic.Although no drug has been developed against the disease, doctors are administering antiviral agents, antibiotics, antipyretics, and other drugs depending on the situation.As the pandemic is prolonged, we must evaluate not only the efficacy of drugs but also their safety.

Methods

From March to May 2020, we collected data of patients diagnosed with COVID-19 from the National Medical Center and 52 local public medical centers.Additionally, we analyzed the adverse drug reactions (ADRs) to prescription ratio for hydroxychloroquine and lopinavir/ritonavir in patients at the National Medical Center.

Results

We collected data of 118 ADR cases from 79 patients.Of these, 42 (53.2%)patients were women with an average age of 54.4 ± 15.9 years, and 37 (46.8%) were men with an average age of 50.0 ± 19.9 years.Among the 118 ADR cases, the most frequently reported drugs are lopinavir/ritonavir (53 cases, 44.9%) and hydroxychloroquine (22 cases, 18.6%).Classified by systemic organ classes, the most frequent ADRs were 61 (51.7%) cases of gastrointestinal system disorders and 24 (20.3%)cases of liver and biliary system disorders.At the National Medical Center, the ADR/prescription ratio was 22.6% for hydroxychloroquine and 38.6% for lopinavir/ritonavir.

Conclusion

The clinical aspects of COVID-19 are still being determined as it is a new infectious disease.Hence, using a pharmacovigilance system will help to better understand the disease.(JPERM 2021;13:17-23)

Zitieren

APA

Jeong, H., Kim, G. H., Ko, S., & Kang, J. E. (2021). Analysis of Adverse Drug Reactions to Common Drugs Administered to COVID-19 Patients: The Role of Pharmacovigilance System in Public Medical Centers. Journal of Pharmacoepidemiology and Risk Management. https://doi.org/10.56142/2022.13.1.17

Vancouver

Jeong H, Kim GH, Ko S, Kang JE. Analysis of Adverse Drug Reactions to Common Drugs Administered to COVID-19 Patients: The Role of Pharmacovigilance System in Public Medical Centers. Journal of Pharmacoepidemiology and Risk Management. 2021. doi:10.56142/2022.13.1.17

BibTeX
@article{Jeong2021,
  author = {Jeong, Hyesu and Kim, Gunn Hee and Ko, Sung-chul and Kang, Ji Eun},
  title = {Analysis of Adverse Drug Reactions to Common Drugs Administered to COVID-19 Patients: The Role of Pharmacovigilance System in Public Medical Centers},
  journal = {Journal of Pharmacoepidemiology and Risk Management},
  year = {2021},
  doi = {10.56142/2022.13.1.17}
}
Kostenlos starten →